T1	Entity 0 9	HER-2/neu
T2	SNP 10 19	Ile655Val
R1	SNP_coupled_gene Arg1:T2 Arg2:T1	
T3	Organic_inorganic_molecules_affected 10 19	Ile655Val
E1	Organic_inorganic_molecules_affected:T3 Theme:T4 Agent:T2
T4	Entity 10 16	Ile655
T5	Association 41 45	risk
E2	Association:T5 bc:T6 snp_int:T2
T6	Cancer 49 62	breast cancer
T7	Entity 92 145	proto-oncogene human epidermal growth factor receptor
R2	Equiv Arg1:T1 Arg2:T7	
T8	Patho_physiology 184 208	malignant transformation
E3	Patho_physiology:T8 Agent:T10
T9	Patho_physiology 213 223	metastasis
E4	Patho_physiology:T9 Agent:T10
T10	SNP 65 84	Genetic alterations
R3	Member Arg1:T10 Arg2:T2	
R4	SNP_coupled_gene Arg1:T10 Arg2:T7	
T11	Organic_inorganic_molecules_affected 278 308	codon 655 isoleucine to valine
E5	Organic_inorganic_molecules_affected:T11 
R5	Equiv Arg1:E1 Arg2:E5	
T12	SNP 278 308	codon 655 isoleucine to valine
R6	Equiv Arg1:T12 Arg2:T2	
T13	Entity 351 357	coding
R7	SNP_location Arg1:T12 Arg2:T13	
T14	Association 373 377	risk
E6	Association:T14 bc:T15 snp_int:T12
T15	Cancer 381 394	breast cancer
T16	Spec 416 428	inconsistent
R8	Speculation_marker Arg1:E6 Arg2:T16	
T17	Spec 448 460	investigated
T18	Association 465 476	association
E7	Association:T18 snp_int:T20 bc:T21
R9	Speculation_marker Arg1:E7 Arg2:T17	
T19	Entity 480 489	HER-2/neu
T20	SNP 490 499	Ile655Val
R10	SNP_coupled_gene Arg1:T20 Arg2:T19	
T22	Entity 548 567	Sudanese population
T21	Cancer 529 542	breast cancer
R11	Population_assignment Arg1:T20 Arg2:T22	
T23	Interaction 586 599	joint effects
E8	Interaction:T23 Entity:T25 Entity2:T27
T24	Entity 603 612	HER-2/neu
T25	SNP 613 621	variants
R12	SNP_coupled_gene Arg1:T25 Arg2:T24	
T26	Entity 650 654	ESR1
T27	SNP 654 659	C325G
R13	SNP_coupled_gene Arg1:T27 Arg2:T26	
T28	Spec 678 684	tested
T29	Association 695 706	association
E9	Association:T29 bc:T30 snp_int:E8
T30	Cancer 712 725	breast cancer
R14	Speculation_marker Arg1:E9 Arg2:T28	
T31	Entity 654 659	C325G
R15	Nucleotide_substitution Arg1:T27 Arg2:T31	
R16	Member Arg1:T25 Arg2:T12	
T32	SNP 810 819	rs1136200
T33	Entity 782 791	HER-2/neu
T34	SNP 792 801	Ile655Val
R17	SNP_coupled_gene Arg1:T34 Arg2:T33	
R18	Equiv Arg1:T34 Arg2:T32	
R19	Equiv Arg1:T34 Arg2:T20	
T35	Entity 1340 1347	Ile/Ile
T36	Entity 1362 1369	Ile/Val
T37	Level 1376 1400	borderline significantly
T38	Effect_Type 1411 1417	higher
T39	Association 1418 1422	risk
E10	Association:T39 bc:T40 snp_int:T42
E11	Association:T39 bc:T40 snp_int:T41
T40	Cancer 1426 1439	breast cancer
R20	Effect_type_marker Arg1:E10 Arg2:T38	
R21	Level_marker Arg1:E10 Arg2:T37	
A1	Effect_Type E10 Increase
T41	SNP 810 819	rs1136200
T42	SNP 810 819	rs1136200
R22	Genotype Arg1:T42 Arg2:T36	
R23	SNP_coupled_gene Arg1:T42 Arg2:T33	
R24	SNP_coupled_gene Arg1:T41 Arg2:T33	
R25	Population_assignment Arg1:T42 Arg2:T22	
R26	Population_assignment Arg1:T41 Arg2:T22	
R27	Genotype Arg1:T41 Arg2:T35	
T43	Entity 1534 1537	age
T44	Entity 1542 1552	menopausal
T45	Neg 1572 1574	no
T46	Entity 1534 1537	age
T47	Entity 1542 1552	menopausal
R28	Negation_marker Arg1:T47 Arg2:T45	
R29	Negation_marker Arg1:T46 Arg2:T45	
R30	Risk_Factor Arg1:T42 Arg2:T46	
R31	Risk_Factor Arg1:T42 Arg2:T44	
R32	Risk_Factor Arg1:T41 Arg2:T43	
R33	Risk_Factor Arg1:T41 Arg2:T47	
R34	Risk_Factor Arg1:T42 Arg2:T43	
R35	Risk_Factor Arg1:T42 Arg2:T47	
R36	Risk_Factor Arg1:T41 Arg2:T44	
R37	Risk_Factor Arg1:T41 Arg2:T46	
T48	Level 1603 1623	significantly higher
T49	Association 1624 1628	risk
E12	Association:T49 bc:T50 snp_int:T52 snp_int2:T55
R38	Level_marker Arg1:E12 Arg2:T48	
A2	Level E12 High
T50	Cancer 1632 1645	breast cancer
T51	Entity 1688 1692	ESR1
T52	SNP 1692 1695	325
T53	Entity 1696 1698	CC
R39	Genotype Arg1:T52 Arg2:T53	
R40	SNP_coupled_gene Arg1:T52 Arg2:T51	
T54	Entity 1737 1746	HER-2/neu
T55	SNP 1746 1757	655 Ile/Val
R41	SNP_coupled_gene Arg1:T55 Arg2:T54	
T56	Entity 1832 1841	HER-2/neu
T57	SNP 1842 1851	Ile655Val
T58	Level 2095 2106	significant
T59	Interaction 2117 2128	interaction
E13	Interaction:T59 Entity:T61 Entity2:T63
R42	Level_marker Arg1:E13 Arg2:T58	
A3	Level E13 High
T60	Entity 2137 2141	ESR1
T61	SNP 2141 2145	325C
R43	SNP_coupled_gene Arg1:T61 Arg2:T60	
T62	Entity 2172 2181	HER-2/neu
T63	SNP 2182 2191	Ile655Val
R44	SNP_coupled_gene Arg1:T63 Arg2:T62	
T64	Spec 2201 2204	may
R45	Speculation_marker Arg1:E13 Arg2:T64	
T65	Level 2229 2235	higher
T66	Association 2236 2240	risk
E14	Association:T66 bc:T67 snp_int:E13
R46	Level_marker Arg1:E14 Arg2:T65	
T67	Cancer 2244 2257	breast cancer
A4	Level E14 High
R47	Speculation_marker Arg1:E14 Arg2:T64	
R48	Equiv Arg1:T61 Arg2:T27	
R49	Population_assignment Arg1:E13 Arg2:T22	
R50	SNP_coupled_gene Arg1:T57 Arg2:T56	
T68	Association 1873 1877	risk
E15	Association:T68 bc:T69 snp_int:T57
T69	Cancer 1881 1894	breast cancer
T70	Level 1899 1921	borderline significant
R51	Level_marker Arg1:E15 Arg2:T70	
T71	Entity 1931 1943	heterozygous
T72	SNP 1842 1851	Ile655Val
R52	Genotype Arg1:T72 Arg2:T71	
R53	SNP_coupled_gene Arg1:T72 Arg2:T56	
T73	Level 1961 1967	higher
T74	Association 1968 1972	risk
E17	Association:T74 bc:T69 snp_int:T72
R54	Level_marker Arg1:E17 Arg2:T73	
A5	Level E17 High
R55	Population_assignment Arg1:T55 Arg2:T22	
T75	Entity 1665 1675	homozygous
R56	Genotype Arg1:T52 Arg2:T75	
T76	Entity 1712 1724	heterozygous
R57	Genotype Arg1:T55 Arg2:T76	
R58	Population_assignment Arg1:T72 Arg2:T22	
R59	Population_assignment Arg1:T57 Arg2:T22	
R60	Population_assignment Arg1:T52 Arg2:T22	
A6	SNP_Type T2 Missense
A7	SNP_Type T12 Missense
A8	SNP_Type T20 Missense
A9	SNP_Type T34 Missense
A10	SNP_Type T55 Missense
A11	SNP_Type T57 Missense
A12	SNP_Type T72 Missense
A13	SNP_Type T63 Missense
